ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,661, issued on Sept. 30, was assigned to ARAMIS BIOTECHNOLOGIES INC. (Quebec, Canada).
"Influenza virus hemagglutinin mutants" was invented by Pierre-Olivier Lavoie (Quebec, Canada), Aurelien Lorin (Quebec, Canada), Alain Doucet (Quebec, Canada), Marc-Andre D'Aoust (Quebec, Canada) and Manon Couture (Quebec, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the production of modified influenza vial proteins in plants. More specifically, the present invention relates to producing and increasing influenza virus-like particle (VLP) production in plants, wherein the VLPs comprise the modified influenza viral protein...